Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Tonix Pharmaceuticals Holding Corp. (TNXP) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Tonix Pharmaceuticals Holding Corp.. Table 2 shows the detailed insider transactions. This company's CIK number is 1430306.
Total stock buying since 2015: $4,677,186.
Total stock sales since 2015: $155,929.
Total stock option exercises since 2015: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 4,668 | $110,260 | 0 | $0 | 0 | $0 |
| 2022 | 120,000 | $58,700 | 0 | $0 | 0 | $0 |
| 2021 | 33,733 | $35,007 | 0 | $0 | 0 | $0 |
| 2020 | 145,741 | $127,791 | 0 | $0 | 0 | $0 |
| 2019 | 50,000 | $94,995 | 0 | $0 | 0 | $0 |
| 2018 | 43,100 | $173,707 | 0 | $0 | 0 | $0 |
| 2017 | 55,300 | $207,198 | 43,072 | $155,929 | 9,750 | $0 |
| 2016 | 1,750,252 | $2,812,213 | 0 | $0 | 3,600 | $0 |
| 2015 | 158,594 | $1,057,315 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-08 | 668 | $24,060 | 0 | $0 | 0 | $0 |
| 2025-05 | 4,000 | $86,200 | 0 | $0 | 0 | $0 |
| 2022-06 | 20,000 | $34,200 | 0 | $0 | 0 | $0 |
| 2022-03 | 100,000 | $24,500 | 0 | $0 | 0 | $0 |
| 2021-09 | 12,000 | $7,320 | 0 | $0 | 0 | $0 |
| 2021-05 | 5,000 | $5,600 | 0 | $0 | 0 | $0 |
| 2021-03 | 16,733 | $22,087 | 0 | $0 | 0 | $0 |
| 2020-12 | 35,000 | $23,800 | 0 | $0 | 0 | $0 |
| 2020-08 | 110,741 | $103,991 | 0 | $0 | 0 | $0 |
| 2019-12 | 20,000 | $23,180 | 0 | $0 | 0 | $0 |
| 2019-03 | 30,000 | $71,815 | 0 | $0 | 0 | $0 |
| 2018-06 | 39,100 | $161,027 | 0 | $0 | 0 | $0 |
| 2018-05 | 4,000 | $12,680 | 0 | $0 | 0 | $0 |
| 2017-12 | 5,300 | $19,133 | 36,967 | $129,812 | 0 | $0 |
| 2017-08 | 20,000 | $60,025 | 0 | $0 | 0 | $0 |
| 2017-06 | 30,000 | $128,040 | 6,105 | $26,117 | 0 | $0 |
| 2017-05 | 0 | $0 | 0 | $0 | 4,875 | $0 |
| 2017-02 | 0 | $0 | 0 | $0 | 4,875 | $0 |
| 2016-11 | 218,000 | $90,544 | 0 | $0 | 0 | $0 |
| 2016-10 | 135,000 | $0 | 0 | $0 | 0 | $0 |
| 2016-09 | 100,000 | $79,200 | 0 | $0 | 0 | $0 |
| 2016-06 | 1,175,000 | $2,361,420 | 0 | $0 | 0 | $0 |
| 2016-05 | 39,252 | $89,763 | 0 | $0 | 0 | $0 |
| 2016-03 | 83,000 | $191,286 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-21 | Taylor Carolyn E. | Buy | 418 | 36.03 | 15,060 |
| 2025-08-20 | Treco James | Buy | 250 | 36.00 | 9,000 |
| 2025-05-15 | Lederman Seth (Chief Executive Officer) | Buy | 4,000 | 21.55 | 86,200 |
| 2022-06-29 | Lederman Seth (Chief Executive Officer) | Buy | 20,000 | 1.71 | 34,200 |
| 2022-03-25 | Lederman Seth (Chief Executive Officer) | Buy | 100,000 | .24 | 24,500 |
| 2021-09-28 | Lederman Seth (Chief Executive Officer) | Buy | 12,000 | .61 | 7,320 |
| 2021-05-25 | Goodman Daniel Wintner | Buy | 5,000 | 1.12 | 5,600 |
| 2021-03-24 | Lederman Seth (Chief Executive Officer) | Buy | 16,733 | 1.32 | 22,087 |
| 2020-12-30 | Lederman Seth (Chief Executive Officer) | Buy | 35,000 | .68 | 23,800 |
| 2020-08-31 | Treco James | Buy | 5,500 | .89 | 4,895 |
| 2020-08-20 | Bell Margaret Smith | Buy | 5,391 | .93 | 4,997 |
| 2020-08-17 | Sullivan Gregory M (Chief Medical Officer) | Buy | 20,000 | 1.03 | 20,600 |
| 2020-08-14 | Treco James | Buy | 4,500 | 1.06 | 4,770 |
| 2020-08-13 | Lederman Seth (Chief Executive Officer) | Buy | 60,000 | .91 | 54,600 |
| 2020-08-13 | Bagger Richard H | Buy | 10,000 | .91 | 9,100 |
| 2020-08-13 | Olukotun Adeoye Y | Buy | 5,350 | .94 | 5,029 |
| 2019-12-03 | Lederman Seth (Chief Executive Officer) | Buy | 20,000 | 1.16 | 23,180 |
| 2019-03-29 | Lederman Seth (Chief Executive Officer) | Buy | 5,000 | 2.49 | 12,440 |
| 2019-03-26 | Lederman Seth (Chief Executive Officer) | Buy | 25,000 | 2.38 | 59,375 |
| 2018-06-29 | Lederman Seth (Chief Executive Officer) | Buy | 500 | 4.64 | 2,320 |
| 2018-06-28 | Lederman Seth (Chief Executive Officer) | Buy | 500 | 4.58 | 2,290 |
| 2018-06-27 | Lederman Seth (Chief Executive Officer) | Buy | 500 | 4.55 | 2,275 |
| 2018-06-25 | Mario Ernest | Buy | 16,500 | 4.48 | 73,920 |
| 2018-06-14 | Saenger Bradley (Chief Financial Officer) | Buy | 300 | 4.10 | 1,230 |
| 2018-06-14 | Morris Jessica Edgar (Chief Operating Officer) | Buy | 300 | 4.19 | 1,257 |
| 2018-06-14 | Sullivan Gregory M (Chief Medical Officer) | Buy | 10,000 | 3.96 | 39,650 |
| 2018-06-12 | Lederman Seth (Chief Executive Officer) | Buy | 3,000 | 4.37 | 13,110 |
| 2018-06-01 | Rhodes John B | Buy | 7,500 | 3.33 | 24,975 |
| 2018-05-25 | Lederman Seth (Chief Executive Officer) | Buy | 4,000 | 3.17 | 12,680 |
| 2017-12-26 | Lederman Seth (Chief Executive Officer) | Buy | 5,300 | 3.61 | 19,133 |
| 2017-12-21 | Mario Ernest | Sale | 5,000 | 3.46 | 17,300 |
| 2017-12-20 | Mario Ernest | Sale | 8,965 | 3.44 | 30,839 |
| 2017-12-19 | Mario Ernest | Sale | 6,035 | 3.51 | 21,182 |
| 2017-12-18 | Mario Ernest | Sale | 10,000 | 3.57 | 35,700 |
| 2017-12-15 | Mario Ernest | Sale | 5,000 | 3.55 | 17,750 |
| 2017-12-14 | Mario Ernest | Sale | 1,967 | 3.58 | 7,041 |
| 2017-08-17 | Lederman Seth (Chief Executive Officer) | Buy | 15,000 | 3.00 | 45,075 |
| 2017-08-16 | Lederman Seth (Chief Executive Officer) | Buy | 5,000 | 2.99 | 14,950 |
| 2017-06-30 | Lederman Seth (Chief Executive Officer) | Buy | 5,000 | 4.33 | 21,640 |
| 2017-06-30 | Mario Ernest | Sale | 6,105 | 4.28 | 26,117 |
| 2017-06-26 | Lederman Seth (Chief Executive Officer) | Buy | 5,000 | 4.40 | 22,000 |
| 2017-06-20 | Lederman Seth (Chief Executive Officer) | Buy | 20,000 | 4.22 | 84,400 |
| 2017-05-27 | Landry Donald W | Option Ex | 750 | .00 | 0 |
| 2017-05-27 | Mather Charles E Iv | Option Ex | 750 | .00 | 0 |
| 2017-05-27 | Saks Samuel R | Option Ex | 750 | .00 | 0 |
| 2017-05-27 | Rhodes John B | Option Ex | 1,125 | .00 | 0 |
| 2017-05-27 | Grace Patrick P | Option Ex | 750 | .00 | 0 |
| 2017-05-27 | Mario Ernest | Option Ex | 750 | .00 | 0 |
| 2017-02-09 | Landry Donald W | Option Ex | 750 | .00 | 0 |
| 2017-02-09 | Mather Charles E Iv | Option Ex | 750 | .00 | 0 |
| 2017-02-09 | Saks Samuel R | Option Ex | 750 | .00 | 0 |
| 2017-02-09 | Rhodes John B | Option Ex | 1,125 | .00 | 0 |
| 2017-02-09 | Grace Patrick P | Option Ex | 750 | .00 | 0 |
| 2017-02-09 | Mario Ernest | Option Ex | 750 | .00 | 0 |
| 2016-11-23 | Mario Ernest | Buy | 120,000 | .41 | 48,600 |
| 2016-11-21 | Lederman Seth (Chief Executive Officer) | Buy | 98,000 | .43 | 41,944 |
| 2016-10-31 | Lederman Seth (Chief Executive Officer) | Buy | 10,000 | .00 | 0 |
| 2016-10-31 | Rhodes John B | Buy | 25,000 | .00 | 0 |
| 2016-10-31 | Mario Ernest | Buy | 100,000 | .00 | 0 |
| 2016-09-13 | Mario Ernest | Buy | 100,000 | .79 | 79,200 |
| 2016-06-22 | Lederman Seth (Chief Executive Officer) | Buy | 20,000 | 2.08 | 41,500 |
| 2016-06-21 | Saenger Bradley (Chief Financial Officer) | Buy | 6,000 | 2.00 | 12,000 |
| 2016-06-21 | Daugherty Bruce (See remarks) | Buy | 300,000 | 2.00 | 600,000 |
| 2016-06-21 | Lederman Seth (Chief Executive Officer) | Buy | 75,000 | 2.00 | 150,000 |
| 2016-06-21 | Saks Samuel R | Buy | 75,000 | 2.00 | 150,000 |
| 2016-06-21 | Rhodes John B | Buy | 75,000 | 2.00 | 150,000 |
| 2016-06-21 | Mario Ernest | Buy | 150,000 | 2.00 | 300,000 |
| 2016-06-03 | Sullivan Gregory M (Chief Medical Officer) | Buy | 20,000 | 2.50 | 49,920 |
| 2016-05-12 | Mario Ernest | Buy | 31,042 | 2.30 | 71,365 |
| 2016-05-11 | Mario Ernest | Buy | 8,210 | 2.24 | 18,398 |
| 2016-03-23 | Lederman Seth (Chief Executive Officer) | Buy | 8,000 | 2.44 | 19,536 |
| 2016-03-16 | Mario Ernest | Buy | 75,000 | 2.29 | 171,750 |
| 2016-02-25 | Landry Donald W | Option Ex | 600 | .00 | 0 |
| 2016-02-25 | Mather Charles E Iv | Option Ex | 600 | .00 | 0 |
| 2016-02-25 | Saks Samuel R | Option Ex | 600 | .00 | 0 |
| 2016-02-25 | Rhodes John B | Option Ex | 600 | .00 | 0 |
| 2016-02-25 | Grace Patrick P | Option Ex | 600 | .00 | 0 |
| 2016-02-25 | Mario Ernest | Option Ex | 600 | .00 | 0 |
| 2015-09-30 | Sullivan Gregory M (Chief Medical Officer) | Buy | 5,000 | 5.18 | 25,900 |
| 2015-09-28 | Sullivan Gregory M (Chief Medical Officer) | Buy | 4,694 | 5.95 | 27,924 |
| 2015-09-28 | Gershell Leland (Chief Financial Officer) | Buy | 400 | 5.83 | 2,330 |
| 2015-09-25 | Lederman Seth (Chief Executive Officer) | Buy | 6,000 | 6.50 | 39,000 |
| 2015-08-26 | Mario Ernest | Buy | 10,000 | 6.05 | 60,500 |
| 2015-08-25 | Mario Ernest | Buy | 1,468 | 6.40 | 9,395 |
| 2015-08-24 | Mario Ernest | Buy | 2,532 | 6.20 | 15,698 |
| 2015-08-20 | Mario Ernest | Buy | 6,000 | 6.64 | 39,870 |
| 2015-08-17 | Mario Ernest | Buy | 15,000 | 6.93 | 104,025 |
| 2015-07-17 | Gershell Leland (Chief Financial Officer) | Buy | 1,000 | 7.50 | 7,500 |
| 2015-07-17 | Lederman Seth (Chief Executive Officer) | Buy | 6,000 | 7.50 | 45,000 |
| 2015-07-17 | Saks Samuel R | Buy | 10,000 | 7.50 | 75,000 |
| 2015-07-17 | Rhodes John B | Buy | 6,000 | 7.50 | 45,000 |
| 2015-07-17 | Mario Ernest | Buy | 25,000 | 7.50 | 187,500 |
| 2015-06-11 | Sullivan Gregory M (Chief Medical Officer) | Buy | 4,500 | 8.38 | 37,710 |
| 2015-03-17 | Lederman Seth (Chief Executive Officer) | Buy | 1,000 | 7.18 | 7,180 |
| 2015-03-16 | Lederman Seth (Chief Executive Officer) | Buy | 1,000 | 6.85 | 6,853 |
| 2015-03-13 | Lederman Seth (Chief Executive Officer) | Buy | 1,000 | 7.21 | 7,210 |
| 2015-03-12 | Lederman Seth (Chief Executive Officer) | Buy | 1,000 | 7.26 | 7,260 |
| 2015-03-11 | Lederman Seth (Chief Executive Officer) | Buy | 1,000 | 7.00 | 7,000 |
| 2015-03-10 | Mather Charles E Iv | Buy | 1,000 | 6.80 | 6,800 |
| 2015-03-10 | Lederman Seth (Chief Executive Officer) | Buy | 1,000 | 6.90 | 6,900 |
| 2015-03-09 | Lederman Seth (Chief Executive Officer) | Buy | 1,000 | 6.50 | 6,500 |
| 2015-03-06 | Lederman Seth (Chief Executive Officer) | Buy | 1,000 | 6.45 | 6,450 |
| 2015-03-06 | Mario Ernest | Buy | 4,000 | 6.57 | 26,280 |
| 2015-03-05 | Lederman Seth (Chief Executive Officer) | Buy | 1,000 | 6.48 | 6,480 |
| 2015-03-04 | Lederman Seth (Chief Executive Officer) | Buy | 1,000 | 6.05 | 6,050 |
| 2015-02-09 | Gershell Leland (Chief Financial Officer) | Buy | 5,000 | 5.85 | 29,250 |
| 2015-02-09 | Lederman Seth (Chief Executive Officer) | Buy | 5,000 | 5.85 | 29,250 |
| 2015-02-09 | Mario Ernest | Buy | 30,000 | 5.85 | 175,500 |
Insider trading activities including stock purchases, stock sales, and option exercises of TNXP listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Tonix Pharmaceuticals Holding Corp. (symbol TNXP, CIK number 1430306) see the Securities and Exchange Commission (SEC) website.